By Peter Yim | Trial Site News | July 26, 2021 Susanna Naggie is leading a nation-wide study of ivermectin, ACTIV-6. She is also a member of the NIH panel that provided the current recommendation on the use of ivermectin in COVID-19 that is at odds with the view of leading physicians and experts in evidence-based medicine: “There are insufficient data […]
Source